Vicarious Surgical (RBOT) Rule 144 Notice: 463 Shares Planned Sale

Rhea-AI Filing Summary

Form 144 filed for Vicarious Surgical Inc. (RBOT) discloses a proposed sale of 463 shares of Class A common stock through UBS Financial Services on 09/03/2025 with an aggregate market value of $2,685. The filing states the shares were acquired by restricted stock lapse on 09/02/2025 and lists total shares outstanding as 5,298,253. The notice also reports three prior sales by the same person during the past three months totaling 1,559 shares with aggregate gross proceeds of $10,040. The filer affirms no undisclosed material adverse information and includes standard signature and legal attestations.

Positive

• Regulatory compliance: The filing provides required Rule 144 details including broker, acquisition method, sale date, and attestations.
• Transparency on acquisition: Specifies the shares were acquired by restricted stock lapse on 09/02/2025.
• Prior sales disclosed: Past three months sales by the same person are listed (1,559 shares, $10,040 gross proceeds).

Negative

• None.

Insights

Securities Analyst

TL;DR: Small-scale insider sale disclosed; transaction size is immaterial versus outstanding shares.

The filing documents a planned brokered sale of 463 Class A shares valued at $2,685, executed via UBS on 09/03/2025. The shares were acquired through restricted stock lapse the prior day, indicating these were newly vested rather than open-market purchases. Recent sales by the same person in the past three months total 1,559 shares for $10,040, showing modest ongoing dispositions. Given outstanding shares of 5,298,253, the absolute and relative sizes are minimal and unlikely to affect company valuation.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 requirements; signer certifies no undisclosed material information.

The form includes required issuer and broker identification, acquisition details indicating a restricted stock lapse, and a representation that no material nonpublic information is known. The presence of recent sale history and explicit attestations supports regulatory compliance and transparency. From a governance standpoint, filings of this size are routine and reflect standard insider vesting and limited resale activity rather than governance changes.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	463	2685	5298253	09/03/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	09/02/2025	Restricted Stock Lapse	Vicarious Surgical Inc.			1349	09/02/2025	Restricted Stock Lapse

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Adam Sachs 78 4th Ave Waltham MA 02451	Class A Common Stock	06/03/2025	463	3210
Adam Sachs 78 4th Ave Waltham MA 02451	Class A Common Stock	06/23/2025	279	2067
Adam Sachs 78 4th Ave Waltham MA 02451	Class A Common Stock	08/20/2025	817	4763

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the RBOT Form 144 filed on this notice disclose?

It discloses a proposed sale of 463 Class A shares via UBS on 09/03/2025 with aggregate market value of $2,685.

How were the shares acquired that are being sold under Rule 144?

The shares were acquired by restricted stock lapse on 09/02/2025, per the filing.

How many Vicarious Surgical shares are outstanding according to the filing?

5,298,253 shares outstanding is the figure reported in the Form 144.

Has the same person sold other RBOT shares recently?

Yes. The filing lists three sales in the past three months totaling 1,559 shares for gross proceeds of $10,040.

Through which broker will the sale be executed?

UBS Financial Services Inc. at the address provided in the filing.